Latest news with #CL
Miami Herald
2 days ago
- Automotive
- Miami Herald
The Rarest Acura Ever Built Has Nothing to Do With the Integra Type R
Ask any Honda and Acura enthusiast what the rarest model the Japanese automaker produced is, and chances are they'll say, "the Integra Type R." It's a solid guess, considering the high-revving performance coupe was only produced for a few short years and in limited numbers, but that's not the correct answer. Look a little deeper into Acura's production history, and you will uncover a model that's even rarer than the beloved Type R. It's so obscure that most people probably don't even know it exists. That model is the 2003 Acura CL Type S with a six-speed manual transmission. Sure, the Acura CL was a popular car, as it was produced from 1997 to 2003. However, nearly all of them were offered with an automatic transmission. It wasn't until its final year that Acura offered a manual option, making this variant a true unicorn. The Acura CL was based on the Honda Accord platform and was essentially sold as a sporty two-door version of the mid-size Acura TL. In its early years, the Acura CL was offered with either a 2.2-liter, four-cylinder engine or a 3.0-liter V6. Positioned between the sporty Integra and the larger TL sedan, the CL offered a comfortable blend of performance and luxury. The CL gained enough popularity that Acura revised it for its second generation, which started in 2001. The redesign included a longer, wider body and sleeker aesthetics inside and out. Under its hood was a larger 3.2-liter V6 engine, as the four-cylinder engine and manual transmission options were dropped entirely in favor of a more powerful Type S variant. However, its performance was initially hampered by a weak point: the automatic transmission. The automatic transmission was notorious for having issues, which included torque converter problems, slipping gears, and premature failure, which was an unfortunate trait shared with other Honda and Acura models at the time. In response, Acura offered a six-speed manual transmission for the 2003 model year, making the CL Type S far more appealing to driving enthusiasts. The manual-equipped 2003 Acura CL Type S boasted 260 horsepower and 232 lb-ft of torque, which allowed it to keep up with the BMW 3 Series at the time. It could dash to highway speeds from a standstill in the low six-second range, all while coddling its occupants in leather-trimmed comfort. The Acura CL was not only about performance, but it was also comfortable. Its interior was adorned with plush leather seats, a sunroof, and a Bose premium audio system. The rear seat area could accommodate two adults, and the cargo area could fit a few suitcases for a weekend getaway. Considering its power and luxury, the CL Type S was more comfortable than the fabled Integra Type R, and it delivered the same amount of performance. The editors at Car and Driver noted, "Not only does this update enhance the driving experience-more interaction between man and machine, less likelihood of excessive cell phone usage-it lends an extra element of sportiness to a car that, for all its excellence, needed it." Since Acura only produced the CL Type S with a manual transmission for one year, finding one in today's market is no easy task. Acura built only 2,690 units without navigation and 820 units with it in the U.S., leaving the grand total at 3,510 units for 2003. It's even rarer in the north, as Canada received just 331 units. By comparison, the Acura produced a total of 3,822 Integra Type R models throughout its four-year production run, which lasted from 1997 to 1998 and then from 2000 to 2001, after a mild refresh. Speaking of rare Acuras, another rarity is the NSX Zanardi Edition, which was a special edition that paid tribute to professional racecar driver Alex Zanardi. Acura only produced 51 of these special edition cars, but it was far more out of reach to the masses due to costing well over $100,000, which was double the Acura CL Type S and Integra Type R's price tags. The CL Type S 6MT, by contrast, remains a little more attainable. Clean examples can be found for anywhere between $10,000 and $20,000 nationwide, depending on the car's condition and location. However, if you do find one, you'll have one of Acura's hidden gems, and you won't have to worry about it getting stolen like the Integra Type R or having to shell out over $100,000 for an NSX Zanardi Edition. Copyright 2025 The Arena Group, Inc. All Rights Reserved.
Yahoo
14-06-2025
- Business
- Yahoo
This Dividend King Just Announced a Quarterly Dividend
Colgate-Palmolive Company (NYSE:CL) is one of the best stocks for a retirement stock portfolio. On June 12, the company announced that its Board of Directors has approved a quarterly cash dividend of $0.52 per share, which will be paid on August 15, 2025, to shareholders on record as of July 18, 2025. An array of toothpaste, toothbrushes, and mouthwashes on a bright background, highlighting the company's oral care products. Though the recent dividend was consistent with the previous dividend, Colgate-Palmolive Company (NYSE:CL) has consistently paid dividends on its common stock since 1895. In addition, the company has raised its payouts for 62 consecutive years. Colgate-Palmolive Company (NYSE:CL) is a purpose-driven and innovative company committed to creating a healthier future for people, pets, and the planet. Its product lineup spans Oral Care, Personal Care, Home Care, and Pet Nutrition, with brands available in over 200 countries and territories around the world. As of June 13, Colgate-Palmolive Company (NYSE:CL) has a dividend yield of 2.30%, and the stock has surged by nearly 3% in the past month. While we acknowledge the potential of CL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Sign in to access your portfolio
Yahoo
13-06-2025
- Business
- Yahoo
Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share
Colgate-Palmolive recently affirmed its commitment to delivering consistent value to shareholders by declaring a quarterly cash dividend of $0.52 per common share. The company's stock price experienced a notable 6% rise over the past month. This period also saw significant executive appointments, a positive indicator of strong leadership continuity. Despite broader market turbulence, including geopolitical tensions pushing the Dow Jones down 1.2%, CL's performance remained robust. These internal developments may have bolstered investor confidence, aligning with the broader market upswing that gained 1.6% over the last 7 days. We've spotted 1 risk for Colgate-Palmolive you should be aware of. We've found 18 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent executive appointments and the declaration of a US$0.52 per share dividend by Colgate-Palmolive may suggest a continuity in strategic vision and commitment to shareholder returns. These developments could reinforce confidence among investors, as reflected in a 6% increase in the stock price over the past month, aligning with the company's resilient performance during a period of broader market volatility. In terms of historical performance, Colgate-Palmolive's shares have achieved a total return of 42.16% over the last five years, showing a strong long-term trajectory despite short-term fluctuations. Over the past year, the company exceeded the US Household Products industry performance, which saw a 2.7% decline, though it underperformed the broader US market's 11.7% return. The company's focus on innovation and premiumization, particularly with product relaunches like Colgate Total and Hill's Science Diet, could drive future revenue and earnings growth. Analysts forecast revenue to grow by 3.4% annually, with earnings expected to reach US$3.5 billion by 2028. Market challenges, particularly tariff impacts and softened conditions in China and Latin America, pose risks to these forecasts. Despite these challenges and the current share price of US$91.0, the analyst consensus price target stands at US$98.76, indicating optimism towards future growth. The modest gap between the current price and the target suggests analysts see Colgate-Palmolive as fairly priced on average, though this requires careful consideration of various growth and risk factors. Review our growth performance report to gain insights into Colgate-Palmolive's future. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
13-06-2025
- Business
- Yahoo
Colgate-Palmolive (NYSE:CL) Declares Quarterly Dividend of US$0.52 Per Share
Colgate-Palmolive recently affirmed its commitment to delivering consistent value to shareholders by declaring a quarterly cash dividend of $0.52 per common share. The company's stock price experienced a notable 6% rise over the past month. This period also saw significant executive appointments, a positive indicator of strong leadership continuity. Despite broader market turbulence, including geopolitical tensions pushing the Dow Jones down 1.2%, CL's performance remained robust. These internal developments may have bolstered investor confidence, aligning with the broader market upswing that gained 1.6% over the last 7 days. We've spotted 1 risk for Colgate-Palmolive you should be aware of. We've found 18 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. The recent executive appointments and the declaration of a US$0.52 per share dividend by Colgate-Palmolive may suggest a continuity in strategic vision and commitment to shareholder returns. These developments could reinforce confidence among investors, as reflected in a 6% increase in the stock price over the past month, aligning with the company's resilient performance during a period of broader market volatility. In terms of historical performance, Colgate-Palmolive's shares have achieved a total return of 42.16% over the last five years, showing a strong long-term trajectory despite short-term fluctuations. Over the past year, the company exceeded the US Household Products industry performance, which saw a 2.7% decline, though it underperformed the broader US market's 11.7% return. The company's focus on innovation and premiumization, particularly with product relaunches like Colgate Total and Hill's Science Diet, could drive future revenue and earnings growth. Analysts forecast revenue to grow by 3.4% annually, with earnings expected to reach US$3.5 billion by 2028. Market challenges, particularly tariff impacts and softened conditions in China and Latin America, pose risks to these forecasts. Despite these challenges and the current share price of US$91.0, the analyst consensus price target stands at US$98.76, indicating optimism towards future growth. The modest gap between the current price and the target suggests analysts see Colgate-Palmolive as fairly priced on average, though this requires careful consideration of various growth and risk factors. Review our growth performance report to gain insights into Colgate-Palmolive's future. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:CL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
11-06-2025
- Business
- Yahoo
Momentum in Pet Business: A Catalyst for CL's Growth Phase?
Colgate-Palmolive Company's CL pet care business remains a core strength and provides a competitive edge. As the pet industry gains traction, demand for high-quality products and services is rising. The advent of online purchasing has further bolstered the pet industry. Hence, CL has been making every possible effort to grab a larger share of the pet company is aggressively expanding its foothold in the pet industry by offering comprehensive pet care solutions. Colgate's pet business, commonly referred to as Hill's Pet Nutrition, remains committed to offering science-led pet nutrition solutions, focused on premium, veterinarian-led pet food. With the help of Hill's Pet Nutrition segment, the company has been a leader in specialty pet nutrition products for dogs and cats, with products marketed in more than 80 countries and territories worldwide. CL also plans to expand into the fresh pet food supplies pet foods under two labels, including Hill's Science Diet and Hill's Prescription Diet. Hill's Science Diet offers a range of products for everyday nutritional needs, whereas Hill's Prescription Diet spans a lineup of therapeutic pet foods to nutritionally aid dogs and cats in diverse stages of health. This February, Colgate has agreed to buy Care TopCo Pty Ltd, owner of the Prime100 pet food brand, to bolster its pet Hill's Pet Nutrition competes globally, selling through veterinarians as well as pet-supply and e-commerce retailers, and DTC channels. In first-quarter 2025, Hill's Pet Nutrition segment delivered sales of $1.1 billion, contributing about 23% to the overall quarterly sales. We expect the Pet Nutrition segment to register year-over-year growth of 1.3% in a nutshell, CL seeks to be a dominant player in the pet market by leveraging its Hill's Pet Nutrition division and expanding in the pet care aisle. This is likely to boost its overall revenues and aid growth. Tractor Supply Company TSCO, Chewy, Inc. CHWY and Central Garden & Pet Company CENT are the key companies competing with Colgate in the pet Supply is CL's key competitor in the pet care market. Tractor Supply has adopted a multi-channel approach, further buoyed by its Neighbor's Club loyalty program. Petsense, which is a fully-owned subsidiary of Tractor Supply and a pet specialty retailer, caters well to the needs of pet owners. TSCO has been striving to become a one-stop shop for pet owners. Pet owners can have easy access to TSCO's pet products, prescription medications and in-store services, including grooming and veterinary care. TSCO's pet business is likely to benefit from Petsense stores, the Allivet integration and the Tractor Supply Rx which operates as an e-commerce retailer for pet food and other related products, has been enhancing its presence in the pet market. CHWY has been making technology upgrades for its website and online platforms to aid online sales and be the perfect destination for pet lovers. Robust active customer growth and engagement, along with high Autoship customer loyalty, have been steadily contributing to its results. CHWY's healthcare business, which offers products and services spanning online pharmacy, telehealth, pet insurance and veterinary-led management tools, is encouraging. Central Garden & Pet has been a market leader in the pet and garden spaces, delivering innovative and trusted solutions. CENT's Pet segment consists of dog and cat supplies like treats and chews, toys, beds and containment, grooming products, waste management and training pads; supplies for aquatics, small animals, reptiles and pet birds such as toys, enclosures and habitats, bedding, food and supplements; products for equine and livestock, animal and household health and insect control products; live fish and small animals, and outdoor cushions. Central Garden & Pet has been advancing its growth strategy through innovation, e-commerce expansion and cost efficiencies across its Pet and Garden segments. Shares of Colgate have gained 2.6% year to date compared with the industry's growth of 0.7%. Image Source: Zacks Investment Research From a valuation standpoint, CL trades at a forward price-to-earnings ratio of 24.40X compared with the industry's average of 20.77X. Image Source: Zacks Investment Research The Zacks Consensus Estimate for CL's 2025 and 2026 EPS indicates year-over-year growth of 1.4% and 7.3%, respectively. The company's EPS estimate for 2025 has been stable, while the same for 2026 has gone north in the past 30 days. Image Source: Zacks Investment Research CL stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tractor Supply Company (TSCO) : Free Stock Analysis Report Colgate-Palmolive Company (CL) : Free Stock Analysis Report Central Garden & Pet Company (CENT) : Free Stock Analysis Report Chewy (CHWY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
